NO20005885D0 - Kombinasjonsterapi for behandling av refraktær depresjon - Google Patents
Kombinasjonsterapi for behandling av refraktær depresjonInfo
- Publication number
- NO20005885D0 NO20005885D0 NO20005885A NO20005885A NO20005885D0 NO 20005885 D0 NO20005885 D0 NO 20005885D0 NO 20005885 A NO20005885 A NO 20005885A NO 20005885 A NO20005885 A NO 20005885A NO 20005885 D0 NO20005885 D0 NO 20005885D0
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- combination therapy
- refractory depression
- refractory
- depression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Oxide Ceramics (AREA)
- Percussion Or Vibration Massage (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8644498P | 1998-05-22 | 1998-05-22 | |
PCT/US1999/011276 WO1999061027A1 (en) | 1998-05-22 | 1999-05-21 | Combination therapy for treatment of refractory depression |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20005885D0 true NO20005885D0 (no) | 2000-11-21 |
NO20005885L NO20005885L (no) | 2001-01-17 |
Family
ID=22198612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20005885A NO20005885L (no) | 1998-05-22 | 2000-11-21 | Kombinasjonsterapi for behandling av refraktær depresjon |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP0958824A3 (no) |
JP (1) | JP2002516282A (no) |
KR (1) | KR20010043730A (no) |
CN (1) | CN1154496C (no) |
AU (1) | AU761510B2 (no) |
BR (1) | BR9911049A (no) |
CA (1) | CA2332814C (no) |
CZ (1) | CZ20004279A3 (no) |
EA (1) | EA004539B1 (no) |
HK (1) | HK1040055B (no) |
HR (1) | HRP20000797A2 (no) |
HU (1) | HUP0101901A3 (no) |
ID (1) | ID26861A (no) |
IL (1) | IL139592A (no) |
MY (1) | MY127938A (no) |
NO (1) | NO20005885L (no) |
NZ (1) | NZ507980A (no) |
PL (1) | PL344331A1 (no) |
SK (1) | SK17512000A3 (no) |
TR (1) | TR200003443T2 (no) |
TW (1) | TWI226829B (no) |
UA (1) | UA78181C2 (no) |
WO (1) | WO1999061027A1 (no) |
ZA (1) | ZA200006815B (no) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000030648A1 (en) * | 1998-11-23 | 2000-06-02 | Sepracor Inc. | 2-hydroxymethylolanzapine compositions and methods |
UA77650C2 (en) * | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
SI1237553T1 (sl) * | 1999-12-06 | 2006-06-30 | Lundbeck & Co As H | Kombinacija inhibitorja ponovnega navzema serotonina in antagonista 5-ht 2c?, inverznega agonista ali delnega agonista |
AU2002232470B2 (en) * | 2001-01-02 | 2005-11-03 | Pharmacia & Upjohn Company Llc | New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
US7973043B2 (en) | 2002-07-30 | 2011-07-05 | Peter Migaly | Combination therapy for depression, prevention of suicide, and various medical and psychiatric conditions |
BR0317771A (pt) | 2002-12-27 | 2005-11-22 | Otsuka Pharma Co Ltd | Composição farmacêutica, uso da mesma, e, método de tratar distúrbios em um paciente |
AR042806A1 (es) | 2002-12-27 | 2005-07-06 | Otsuka Pharma Co Ltd | Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo |
FR2851163B1 (fr) * | 2003-02-14 | 2007-04-27 | Utilisation de l'enantiomere dextrogyre du milnacipran pour la preparation d'un medicament | |
BRPI0413750A (pt) * | 2003-09-04 | 2006-10-24 | Lundbeck & Co As H | uso de loxapina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, e, kit |
CN103788089A (zh) | 2003-09-17 | 2014-05-14 | 詹森药业有限公司 | 作为血清素受体调节剂的稠合杂环化合物 |
WO2005053703A1 (en) | 2003-12-02 | 2005-06-16 | Leslie James Sheldon | Combination therapy for dementia, depression and apathy |
JP2007513896A (ja) * | 2003-12-15 | 2007-05-31 | ハー・ルンドベック・アクチエゼルスカベット | セロトニン再取り込み阻害剤およびヒスタミン3受容体アンタゴニスト、インバースアゴニストまたはパーシャルアゴニストの併用 |
US7598255B2 (en) | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
JP2009506069A (ja) * | 2005-08-26 | 2009-02-12 | ブレインセルス,インコーポレイティド | ムスカリン性受容体調節による神経発生 |
WO2007144005A1 (en) | 2006-06-16 | 2007-12-21 | H. Lundbeck A/S | 1- [2- (2, 4-dimethylphenylsulfanyl) -phenyl] piperazine as a compound with combined serotonin reuptake, 5-ht3 and 5-ht1a activity for the treatment of cognitive impairment |
JP5467870B2 (ja) * | 2007-02-09 | 2014-04-09 | アルファファーム ピーティーワイ リミテッド | 異なる物理的形態の2種以上の有効医薬成分を含有する投薬形態 |
TWI432194B (zh) * | 2007-03-20 | 2014-04-01 | Lundbeck & Co As H | 4-〔2-(4-甲基苯硫基)苯基〕哌啶之新穎治療用途 |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
CN105769875A (zh) * | 2014-12-22 | 2016-07-20 | 扬子江药业集团上海海尼药业有限公司 | 复方奥氮平盐酸氟西汀胶囊的制备方法 |
CN108938645A (zh) * | 2018-08-24 | 2018-12-07 | 山西医科大学第医院 | 一种抗精神病药物组合物 |
CN111084778B (zh) * | 2019-12-31 | 2022-06-24 | 北京鑫开元医药科技有限公司 | 一种奥氮平盐酸氟西汀胶囊及其制备方法 |
CN114569566A (zh) * | 2020-12-02 | 2022-06-03 | 四川科瑞德制药股份有限公司 | 一种盐酸米那普仑制剂的制备方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU8072691A (en) * | 1990-06-28 | 1992-01-23 | Beecham Group Plc | Pharmaceutical preparations |
FR2716680B1 (fr) * | 1994-02-25 | 1996-04-05 | Adir | Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
HUP9903679A3 (en) * | 1996-03-11 | 2001-10-29 | Lilly Co Eli | Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder |
CN1146421C (zh) * | 1996-03-25 | 2004-04-21 | 伊莱利利公司 | 治疗疼痛的组合物以及药物在制备所述组合物中的应用 |
ZA977967B (en) * | 1996-09-23 | 1999-03-04 | Lilly Co Eli | Combination therapy for treatment of psychoses |
-
1999
- 1999-05-21 HU HU0101901A patent/HUP0101901A3/hu unknown
- 1999-05-21 EP EP99303969A patent/EP0958824A3/en not_active Withdrawn
- 1999-05-21 CA CA002332814A patent/CA2332814C/en not_active Expired - Fee Related
- 1999-05-21 UA UA2000116623A patent/UA78181C2/uk unknown
- 1999-05-21 TW TW088108382A patent/TWI226829B/zh not_active IP Right Cessation
- 1999-05-21 NZ NZ507980A patent/NZ507980A/en unknown
- 1999-05-21 CN CNB998090719A patent/CN1154496C/zh not_active Expired - Fee Related
- 1999-05-21 JP JP2000550487A patent/JP2002516282A/ja active Pending
- 1999-05-21 BR BR9911049-0A patent/BR9911049A/pt not_active Application Discontinuation
- 1999-05-21 CZ CZ20004279A patent/CZ20004279A3/cs unknown
- 1999-05-21 SK SK1751-2000A patent/SK17512000A3/sk unknown
- 1999-05-21 AU AU40086/99A patent/AU761510B2/en not_active Ceased
- 1999-05-21 MY MYPI99002017A patent/MY127938A/en unknown
- 1999-05-21 ID IDW20002339A patent/ID26861A/id unknown
- 1999-05-21 TR TR2000/03443T patent/TR200003443T2/xx unknown
- 1999-05-21 PL PL99344331A patent/PL344331A1/xx not_active Application Discontinuation
- 1999-05-21 IL IL13959299A patent/IL139592A/xx not_active IP Right Cessation
- 1999-05-21 KR KR1020007013059A patent/KR20010043730A/ko active IP Right Grant
- 1999-05-21 WO PCT/US1999/011276 patent/WO1999061027A1/en not_active Application Discontinuation
- 1999-05-21 EA EA200001218A patent/EA004539B1/ru not_active IP Right Cessation
-
2000
- 2000-11-20 HR HR20000797A patent/HRP20000797A2/hr not_active Application Discontinuation
- 2000-11-21 ZA ZA200006815A patent/ZA200006815B/en unknown
- 2000-11-21 NO NO20005885A patent/NO20005885L/no unknown
-
2002
- 2002-02-28 HK HK02101563.3A patent/HK1040055B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2002516282A (ja) | 2002-06-04 |
CN1154496C (zh) | 2004-06-23 |
EP0958824A2 (en) | 1999-11-24 |
CA2332814A1 (en) | 1999-12-02 |
IL139592A (en) | 2005-08-31 |
SK17512000A3 (sk) | 2002-02-05 |
NO20005885L (no) | 2001-01-17 |
EA004539B1 (ru) | 2004-06-24 |
CA2332814C (en) | 2008-11-04 |
EP0958824A3 (en) | 1999-12-01 |
ID26861A (id) | 2001-02-15 |
BR9911049A (pt) | 2001-02-06 |
IL139592A0 (en) | 2002-02-10 |
CN1311681A (zh) | 2001-09-05 |
WO1999061027A1 (en) | 1999-12-02 |
CZ20004279A3 (cs) | 2001-09-12 |
UA78181C2 (en) | 2007-03-15 |
NZ507980A (en) | 2003-10-31 |
HK1040055B (zh) | 2005-04-01 |
HRP20000797A2 (en) | 2001-10-31 |
PL344331A1 (en) | 2001-11-05 |
AU761510B2 (en) | 2003-06-05 |
HK1040055A1 (en) | 2002-05-24 |
EA200001218A1 (ru) | 2001-06-25 |
KR20010043730A (ko) | 2001-05-25 |
HUP0101901A3 (en) | 2002-06-28 |
TR200003443T2 (tr) | 2001-03-21 |
HUP0101901A2 (hu) | 2001-11-28 |
ZA200006815B (en) | 2002-01-14 |
AU4008699A (en) | 1999-12-13 |
MY127938A (en) | 2007-01-31 |
TWI226829B (en) | 2005-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20005885L (no) | Kombinasjonsterapi for behandling av refraktær depresjon | |
NO20013369D0 (no) | Arylpiperazinyl-cykloheksyl-indol-derivater for behandling av depresjon | |
NO20005884D0 (no) | Kombinasjonsterapi for behandling av bipolare forstyrrelser | |
NO991381L (no) | Kombinasjonsterapi for behandling av psykoser | |
NO20005864D0 (no) | Quinasoler til behandling av hjernesvulst | |
NO20010882D0 (no) | Terapier for behandling av lungesykdommer | |
EP1077704A4 (en) | COMBINATION THERAPY FOR TREATING DEPRESSION | |
NO20022087L (no) | Fremgangsmåte for behandling av diabetes | |
IL136960A0 (en) | Combination therapy for the treatment of migraine | |
NO20003229L (no) | Kombinasjon av benzosykloheptapyridinforbindelser og antineoplastiske midler for behandling av proliferaktive sykdommer | |
ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
NO20020784L (no) | Medikament for behandling av brudd | |
HUP0101947A3 (en) | Combination for the treatment of tumors | |
NO994258L (no) | Anvendelse av levobupivakain for behandling av ansiktsmigrene | |
NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
NO20002481D0 (no) | Kombinasjonsterapi for behandling av AIDS | |
NO20012612L (no) | Isonipecotamider for behandlingen av integrin-formidlede sykdommer | |
IL136962A0 (en) | Combination therapy for the treatment of migraine | |
IL136025A0 (en) | Combination therapy for the treatment of migraine | |
IL136024A0 (en) | Combination therapy for the treatment of migraine | |
NO20011268D0 (no) | Forbindelse til behandling av depresjon | |
NO996166L (no) | FremgangsmÕte for behandling av avluter | |
NO20042166L (no) | Kombinasjonsterapi for behandling av sykdom | |
GB9926985D0 (en) | Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases | |
ID24439A (id) | Penggunaan tiazolidindion untuk pengobatan hiperglikemia |